| Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate N Fujimoto, S Yeh, HY Kang, S Inui, HC Chang, A Mizokami, C Chang Journal of Biological Chemistry 274 (12), 8316-8321, 1999 | 376 | 1999 |
| Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator K Nishimura, HJ Ting, Y Harada, T Tokizane, N Nonomura, HY Kang, ... Cancer research 63 (16), 4888-4894, 2003 | 138 | 2003 |
| Risk factors for prostate carcinoma in Taiwan: a case–control study in a Chinese population JFC Sung, RS Lin, YS Pu, YC Chen, HC Chang, MK Lai Cancer 86 (3), 484-491, 1999 | 110 | 1999 |
| Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway J Ni, X Wen, J Yao, HC Chang, Y Yin, M Zhang, S Xie, M Chen, B Simons, ... Cancer research 65 (21), 9807-9816, 2005 | 109 | 2005 |
| Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts S Yu, CR Yeh, Y Niu, HC Chang, YC Tsai, HL Moses, CR Shyr, C Chang, ... The Prostate 72 (4), 437-449, 2012 | 104 | 2012 |
| Differential induction of androgen receptor transactivation by different androgen receptor coativators in human prostate cancer DU 145 cells S Yeh, HY Kang, H Miyamoto, K Nishimura, HC Chang, HJ Ting, ... Endocrine 11, 195-202, 1999 | 104 | 1999 |
| Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer S Wen, HC Chang, J Tian, Z Shang, Y Niu, C Chang The American journal of pathology 185 (2), 293-301, 2015 | 103 | 2015 |
| Epidemiology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study WY Huang, YF Chen, S Carter, HC Chang, CF Lan, KH Huang The Journal of urology 189 (6), 2158-2163, 2013 | 103 | 2013 |
| Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells ST Chu, HH Cheng, CJ Huang, HC Chang, CC Chi, HH Su, SS Hsu, ... Life sciences 80 (4), 364-369, 2007 | 99 | 2007 |
| Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→ miRNA-541→ androgen receptor (AR)→ MMP9 signaling S Hu, L Li, S Yeh, Y Cui, X Li, HC Chang, J Jin, C Chang Molecular oncology 9 (1), 44-57, 2015 | 86 | 2015 |
| Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells S Altuwaijri, KH Chuang, KP Lai, JJ Lai, HY Lin, FM Young, A Bottaro, ... Molecular Endocrinology 23 (4), 444-453, 2009 | 81 | 2009 |
| Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy YJ Lee, KH Huang, HJ Yang, HC Chang, J Chen, TK Yang Urolithiasis 41, 247-252, 2013 | 75 | 2013 |
| Altered prostate epithelial development and IGF‐1 signal in mice lacking the androgen receptor in stromal smooth muscle cells S Yu, C Zhang, CC Lin, Y Niu, KP Lai, H Chang, SD Yeh, C Chang, S Yeh The Prostate 71 (5), 517-524, 2011 | 75 | 2011 |
| Androgen Receptor (AR) NH2- and COOH-Terminal Interactions Result in the Differential Influences on the AR-Mediated Transactivation and Cell Growth CL Hsu, YL Chen, HJ Ting, WJ Lin, Z Yang, Y Zhang, L Wang, CT Wu, ... Molecular endocrinology 19 (2), 350-361, 2005 | 75 | 2005 |
| Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types S Altuwaijri, D Kun Lee, KH Chuang, HJ Ting, Z Yang, Q Xu, MY Tsai, ... Endocrine 25, 27-32, 2004 | 75 | 2004 |
| Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators S Yeh, HC Chang, H Miyamoto, H Takatera, M Rahman, HY Kang, ... The Keio journal of medicine 48 (2), 87-92, 1999 | 73 | 1999 |
| A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth H Miyamoto, M Rahman, H Takatera, HY Kang, S Yeh, HC Chang, ... Journal of Biological Chemistry 277 (7), 4609-4617, 2002 | 72 | 2002 |
| CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells M Chen, J Ni, HC Chang, CY Lin, M Muyan, S Yeh Carcinogenesis 30 (5), 841-850, 2009 | 70 | 2009 |
| Appropriate cut-off value for follicle-stimulating hormone in azoospermia to predict spermatogenesis SC Chen, JT Hsieh, HJ Yu, HC Chang Reproductive Biology and Endocrinology 8, 1-5, 2010 | 69 | 2010 |
| Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells→ androgen receptor (AR)→ miRNA32 signals Q Dang, L Li, H Xie, D He, J Chen, W Song, LS Chang, HC Chang, S Yeh, ... Molecular oncology 9 (7), 1241-1251, 2015 | 66 | 2015 |
